35 results on '"Hageman, Lindsey"'
Search Results
2. Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy in Cancer Survivors: A Report From COG-ALTE03N1, BMTSS, and CCSS
3. Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS report
4. Prediction of Coronary Heart Disease Events in Blood or Marrow Transplantation Recipients
5. Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children’s Oncology Group study AALL03N1 report
6. Risk of COVID-19 infection in long-term survivors of blood or marrow transplantation: a BMTSS report
7. Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A COG-ALTE03N1 Report
8. Neighborhood disadvantage, health status, and health care utilization after blood or marrow transplant: BMTSS report
9. Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS report
10. Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model
11. Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study
12. Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 report
13. Burden of Morbidity after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A BMT Survivor Study Report
14. Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study
15. Reduction in Late Mortality Among Patients With Multiple Myeloma Treated With Autologous Peripheral Blood Stem Cell Transplantation—A Blood or Marrow Transplant Survivor Study Report
16. Specific Clonal Mutations Are Predictive of Therapy-Related Myeloid Neoplasms (tMN) after Autologous Peripheral Blood Stem Cell Transplantation (aPBSCT) for Lymphoma
17. Late Morbidity and Mortality after Autologous Blood or Marrow Transplantation (BMT) for Lymphoma in Children, Adolescents and Young Adults - a Report from the BMT Survivor Study (BMTSS)
18. Symptom Cluster (sleep, fatigue, anxiety, and depression) and Cognitive Functioning in Hematologic Malignancy Patients Treated with Blood or Marrow Transplant (BMT)
19. Processing Speed Improvement in Hematologic Cancer Survivors Treated with Allogeneic Blood or Marrow Transplantation- a Randomized Online Cognitive Training Intervention
20. Individual Prediction of Cardiovascular Events in Blood or Marrow Transplant Survivors - a BMT Survivor Study Report
21. Poverty during Maintenance and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): A Report from Children's Oncology Group Study (COG-AALL03N1)
22. 60 - Conditioning Intensity and Chronic Health Conditions (CHCs) after Allogeneic Blood or Marrow Transplantation (BMT): A Report from the BMT Survivor Study (BMTSS)
23. Subsequent Malignant Neoplasms of the Gastrointestinal Tract after Blood or Marrow Transplantation - a BMTSS Report
24. 452 - Chronic Health Conditions (CHCs) after Allogeneic Blood or Marrow Transplantation (BMT) for Inborn Errors of Metabolism (IEM) – a BMT Survivor Study (BMTSS) Report
25. Stroke Risk in Blood or Marrow Transplant (BMT) Survivors - a Report from the BMT Survivor Study (BMTSS)
26. Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial
27. 11 - Late Mortality in Patients Transplanted for Inborn Errors of Metabolism (IEM) – A Report From the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)
28. Decline in Late Mortality after Allogeneic Blood or Marrow Transplantation (alloBMT) Performed in Childhood: a Report from the BMT Survivor Study-2 (BMTSS-2)
29. Reduction in Late Mortality after Autologous Blood or Marrow Transplantation (autoBMT) in Childhood - a Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)
30. Long-Term Morbidity Associated with Chronic Graft Vs. Host Disease (cGvHD) - a Blood or Marrow Transplant Survivor Study (BMTSS)
31. 254 - Long-Term Healthcare Utilization By Older Survivors of Hematopoietic Cell Transplant (HCT): A Report from BMTSS-2
32. 6-Mercaptopurine (6MP) Intake during Maintenance for Childhood Acute Lymphoblastic Leukemia (ALL) - a Comparison of Self-Report and Electronic Monitoring: A Report from the Children's Oncology Group (COG) Study AALL03N1
33. Cytopenias in the Early Post-Autologous Hematopoietic Cell Transplantation (aHCT) Period Predict for Subsequent Development of Therapy-Related Myelodysplasia/ Acute Myeloid Leukemia (t-MDS/AML) Among Patients with Lymphoma
34. Nonadherence to Oral 6-Mercaptopurine (6MP) in a Multi-Ethnic Cohort of Children with Acute Lymphoblastic Leukemia (ALL) and Its Impact On Relapse – a Children’s Oncology Group (COG) Study (AALL03N1)
35. Prevalence and Predictors of Non-Adherence to 6-Mercaptopurine (6MP) in Children with Acute Lymphoblastic Leukemia (ALL) - a Children's Oncology Group Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.